Company / FCF Margin
AbbVie FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
29.1%
FY2025
5-year range
29.1% / 41.8%
FY2021-FY2025
Trend
-8.0%
vs FY2024
Sector context
#16 of 131
Health Care
What the data says
AbbVie's fcf margin of 29.1% is higher than 88% of companies in the Health Care sector (FY2025). FCF Margin has declined for 3 consecutive years, from 41.8% in FY2022 to 29.1% in FY2025.
Based on SEC 10-K filings.
29.1% in FY2025 with a 5-year CAGR of -7.5%. Top quartile in the Health Care sector.
Declined from 40.6% to 29.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -12.6pp
- 5-Year Change
- -7.5pp
- 10-Year Change
- -
Sector benchmark
Top 12% in Health CareTop 12% of 131This company 29.1% Sector average -646.9%
▼
+104.5% above sector average
Key checks
Key Insights
- AbbVie's fcf margin has declined for 3 consecutive years.
- In FY2025, fcf margin decreased 8.0% year-over-year.
- Currently 676.1pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 29.1% | -8.0% |
| FY2024 | 31.6% | -22.1% |
| FY2023 | 40.6% | -2.8% |
| FY2022 | 41.8% | +6.7% |
| FY2021 | 39.1% | +6.7% |
| FY2020 | 36.7% | -4.5% |
| FY2019 | 38.4% | -1.7% |
| FY2018 | 39.1% | +16.8% |
| FY2017 | 33.4% | +30.6% |
| FY2016 | 25.6% | -16.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026